Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Axilla and Upper Limb (C81.34)

Name of the Condition

• Common Name: Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Axilla and Upper Limb
• Medical Terms: LD Hodgkin Lymphoma, Lymphocyte-Depleted Hodgkin Disease (axilla and upper limb lymph nodes)

Summary

Lymphocyte depleted Hodgkin lymphoma (LD Hodgkin lymphoma) is a rare and aggressive subtype of Hodgkin lymphoma. It is characterized by a scarcity of lymphocytes and a predominance of Reed-Sternberg cells in affected lymph nodes or tissues. This subtype often presents at an advanced stage and may involve extranodal sites, such as the liver or bone marrow. LD Hodgkin lymphoma is associated with a poorer prognosis compared to other Hodgkin lymphoma subtypes, though treatment advances have improved outcomes.

Causes

The exact cause of lymphocyte depleted Hodgkin lymphoma is not fully understood. It is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is frequently associated with LD Hodgkin lymphoma, suggesting a potential viral role in its development. Genetic abnormalities and immune system dysregulation may also contribute.

Risk Factors

• Age: Most commonly diagnosed in adults, particularly those over 50.
• Immune Status: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) increases risk.
• Epstein-Barr Virus: Prior infection is strongly associated with this subtype.

Symptoms

Symptoms may include painless swelling of lymph nodes in the axilla or upper limb, fever, night sweats, unexplained weight loss, and fatigue. Advanced cases may present with systemic symptoms like pruritus or lymphadenopathy in other regions.

Diagnosis

Diagnosis involves a biopsy of the affected lymph node, typically showing Reed-Sternberg cells with a lymphocyte-depleted background. Imaging (e.g., CT or PET scans) assesses disease extent, and staging determines involvement of other sites.

Treatment Options

Treatment usually involves chemotherapy, often combined with radiation for localized disease. Stem cell transplantation may be considered for relapsed or refractory cases. Immunotherapy or targeted therapies are under investigation for advanced disease.

Prognosis and Follow-Up

Prognosis is generally poorer than other Hodgkin lymphoma subtypes but has improved with modern therapies. Follow-up includes regular imaging and clinical evaluations to monitor for recurrence or treatment-related complications.

Complications

Complications may include treatment-related toxicities (e.g., myelosuppression, secondary malignancies), disease progression, or long-term organ damage from advanced disease.

Lifestyle & Prevention

No specific preventive measures exist, but maintaining overall health and immune function may support recovery. Avoiding known risk factors (e.g., immunosuppression) is advisable when possible.

When to Seek Professional Help

Seek care if persistent lymph node swelling, unexplained weight loss, or systemic symptoms (fever, night sweats) occur. Prompt evaluation is critical for early diagnosis and management.

Tips for Medical Coders

Code C81.34 is specific to lymphocyte depleted Hodgkin lymphoma involving the lymph nodes of the axilla and upper limb. Ensure documentation specifies the site and subtype to justify this code. Verify that the diagnosis aligns with histopathological findings and clinical presentation to support accurate coding.